GLP1-RAs in Type 1 Diabetes: Dosing and Pharmacokinetics
As we discussed in the previous article, people are starting to use incretins as an adjunct therapy in the treatment of type 1 diabetes. All […]
variability
What goes up…. Must come down. Unless you’re a #PWT1D using #Fiasp.
So then. 10 days after switching back to Novorapid because I was having a devil of a time with the Fiasp, I received a new […]